Gallic acid potentiates the tumour-killing function of CD8+ T cells in gastric cancer
GA restored the impaired cytotoxic function of tumour-infiltrating CD8+ T cells in gastric cancer. These findings position GA as a potential novel immunomodulatory agent for improving anti-tumour immunity in gastric cancer treatment.
Authors
- Meixu Lei (ORCID: https://orcid.org/0009-0008-0382-2321)
- Qi Wang (ORCID: https://orcid.org/0000-0002-1588-9047)
- Si Chen (ORCID: https://orcid.org/0000-0002-0579-5581)
- Yali Zhou (ORCID: https://orcid.org/0000-0003-2074-443X)
- Xuejie Su
- Yifei Shen (ORCID: https://orcid.org/0000-0003-4745-9145)
- Haibin Wang (ORCID: https://orcid.org/0000-0001-6325-5105)
- Hengxin Wang
- Yumin Li (ORCID: https://orcid.org/0009-0002-1069-4934)
Institutions
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/jpp/rgaf087
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00